-The Business Standard Yogender Alagh who headed first ever task force on poverty line in 1978 is dismissive of present methodology devised by Suresh Tendulkar The Planning Commission has issued poverty estimates based on the Suresh Tendulkar methodology, while admitting it was not taking this seriously. Which is also what quite a few statisticians feel about these estimates, including the man regarded as the father of India's first official poverty line...
More »SEARCH RESULT
New drug pricing creates artificial scarcity-Shyama Rajagopal
-The Hindu Kochi: An artificial scarcity of drugs looms large with the new drug pricing regime, slashing prices for 348 essential drugs, set to prevail from July 29. Many retailers who stock medicines for a week are not picking up medicines and are keeping a minimum inventory. Some retailers said distributors were not making medicines available. It has sent medical retail stores into a tizzy about the fate of already available stocks. J.S....
More »It really is the economy, stupid-Rukmini S
-The Hindu Development, price rise and jobs will be the overriding voter concerns in 2014 Lok Sabha poll Results from a nearly 20,000-strong opinion poll conducted by the Centre for the Study of Developing Societies (CSDS) for CNN-IBN and The Hindu indicate that ‘development and the economy' and ‘price rise' will dominate voter concerns in 2014. Corruption comes in at a distant fifth, just half as important to voters as ‘development and...
More »Food for thought in a mid-day meal tragedy-Amarjeet Sinha
-The Business Standard The tragedy involving the death of children in a Bihar school should reinforce recent efforts to improve the programme, notes Amarjeet Sinha. The sad loss of 23 innocent lives after consuming hot cooked meals in a school in Bihar has rightly shocked and angered people. The highly poisonous pesticide monocrotophos found in children's food and a headmistress overlooking the cook and the children's protests about the oil and not...
More »Price control, IP Act & regulatory framework: Revisiting some imp issues about Indian pharma-Ramesh Adige
-The Economic Times Over a year ago, I had written a piece, Quo Vadis, Indian Pharma? (ET, May 11, 2012), in this column. Some key issues were highlighted in the article. Perhaps it is time to revisit the subject and bring out some current issues. Price control: Hurray, the department of pharmaceuticals has come out with a new non-intrusive price control methodology, moving from the cost-based model to the average market price...
More »